UK Facial Injectable Market Size & Outlook, 2023-2030
UK facial injectable market, 2018-2030 (US$M)
Related Markets
UK facial injectable market highlights
- The UK facial injectable market generated a revenue of USD 370.7 million in 2023 and is expected to reach USD 804.7 million by 2030.
- The UK market is expected to grow at a CAGR of 11.7% from 2024 to 2030.
- In terms of segment, botulinum toxin type a was the largest revenue generating product in 2023.
- Botulinum Toxin Type A is the most lucrative product segment registering the fastest growth during the forecast period.
Facial injectable market data book summary
| Market revenue in 2023 | USD 370.7 million |
| Market revenue in 2030 | USD 804.7 million |
| Growth rate | 11.7% (CAGR from 2023 to 2030) |
| Largest segment | Botulinum toxin type a |
| Fastest growing segment | Botulinum Toxin Type A |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Collagen, Botulinum Toxin Type A, HA, CaHA, Polymer Fillers |
| Key market players worldwide | Ipsen SA, AbbVie Inc, Medytox, Revance Therapeutics Inc, Galderma Group AG Registered Shares, Sinclair Pharma plc, Merz Pharma |
Other key industry trends
- In terms of revenue, UK accounted for 3.1% of the global facial injectable market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Italy facial injectable market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 804.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Facial Injectable Market Scope
Facial Injectable Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
UK facial injectable market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to facial injectable market will help companies and investors design strategic landscapes.
Botulinum toxin type a was the largest segment with a revenue share of 55.33% in 2023. Horizon Databook has segmented the UK facial injectable market based on collagen, botulinum toxin type a, ha, caha, polymer fillers covering the revenue growth of each sub-segment from 2018 to 2030.
The growing number of nonsurgical procedures in the country is expected to boost the market over the forecast period. According to the ISAPS 2022 report, nearly 77,924 nonsurgical procedures were performed in the country, of which nearly 64,000 were injectable procedures.
In addition, nearly 35,000 botulinum toxin and 27,000 HA-based procedures were performed in 2022. According to the same report, it was estimated that nearly 600 surgeons were registered in the country. Moreover, the country is rapidly changing its regulations for facial injectables due to practitioner malpractices.
For instance, in September 2023, a government consultation program was launched to improve the clinical practices related to dermal fillers and Botox procedures. According to a government-approved register, Save Face, nearly 3,000 complaints were received in 2022, of which 65% to 67% were related to dermal fillers and nearly 25% were related to Botox.
Reasons to subscribe to UK facial injectable market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of UK facial injectable market databook
-
Our clientele includes a mix of facial injectable market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the UK facial injectable market , including forecasts for subscribers. This country databook contains high-level insights into UK facial injectable market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
UK facial injectable market size, by product, 2018-2030 (US$M)
UK Facial Injectable Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
